Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy.
Zhang Y, Zhang Y, Tao H, Zhu J, Lu Y, Cheng F, Xiong Y, Liu J, Cai G, Zhang Z, Liang H, Chen Y, Zhang W.
Zhang Y, et al. Among authors: liu j.
Cancer Lett. 2023 Nov 1;576:216405. doi: 10.1016/j.canlet.2023.216405. Epub 2023 Sep 30.
Cancer Lett. 2023.
PMID: 37783391